Generation and Characterization Of a Third Party GMP Grade Bank Of CMV Specific T-Cells For Adoptive Immunotherapy Of CMV Infections In Recipients Of HSCT From Cord Blood Or Seronegative Donors

被引：2
|
作者：
Hasan, Aisha N.
Doubrovina, Ekaterina
Koehne, Guenther
Prockop, Susan E.
O'Reilly, Richard J.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2021.2021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2021
引用
收藏
页数：2
相关论文
共 23 条
  • [1] Generation and Characterization of a Third Party GMP Grade Bank of CMV Specific T-Cells for Adoptive Immunotherapy of CMV Infections in Recipients of HSCT from Cord Blood or Seronegative Donors
    Hasan, Aisha Nasreen
    Doubrovina, Ekaterina S.
    Koehne, Guenther
    Prockop, Susan E.
    O'Reilly, Richard
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S131 - S132
  • [2] Generation of CMV Specific T Cells From CMV Seronegative Donors by T Cell Receptor RNA Transfer.
    Thomas, Simone
    Klobuch, Sebastian
    Heemskerk, Mirjam H. M.
    Stolle, Diana
    Besold, Katrin
    Plachter, Bodo
    Schaft, Niels
    Theobald, Matthias
    Voss, Ralf H.
    Herr, Wolfgang
    BLOOD, 2009, 114 (22) : 1386 - 1386
  • [3] CMV-Reactive Gamma/Delta T Cells Expanded From CMV Seronegative Normal Healthy Individuals Lyse CMV-Infected Targets - Potential Adoptive Immunotherapy for Recipients of Stem Cell Transplants From CMV Seronegative Donors
    Knight, Andrea
    Mackinnon, Stephen
    Lowdell, Mark W.
    BLOOD, 2009, 114 (22) : 880 - 880
  • [4] NAIVE T CELLS FROM CORD BLOOD AND CMV-SERONEGATIVE DONORS RECOGNIZE ATYPICAL EPITOPES OF CMVpp65 AND CAN BE USED FOR ADOPTIVE IMMUNOTHERAPY
    Hanley, P. J.
    Lam, S.
    Cruz, C. R. Y.
    Savoldo, B.
    Benjamin, T.
    Stephanie, K.
    Lilleri, D.
    Gerna, G.
    Demmler-Harrison, G.
    Dotti, G.
    Heslop, H. E.
    Brenner, M. K.
    Rooney, C. M.
    Shpall, E. J.
    Rodgers, J. R.
    Bollard, C. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S213 - S213
  • [5] Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
    Neuenhahn, M.
    Albrecht, J.
    Odendahl, M.
    Schlott, F.
    Doessinger, G.
    Schiemann, M.
    Lakshmipathi, S.
    Martin, K.
    Bunjes, D.
    Harsdorf, S.
    Weissinger, E. M.
    Menzel, H.
    Verbeek, M.
    Uharek, L.
    Kroeger, N.
    Wagner, E.
    Kobbe, G.
    Schroeder, T.
    Schmitt, M.
    Held, G.
    Herr, W.
    Germeroth, L.
    Bonig, H.
    Tonn, T.
    Einsele, H.
    Busch, D. H.
    Grigoleit, G. U.
    LEUKEMIA, 2017, 31 (10) : 2161 - 2171
  • [6] Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
    M Neuenhahn
    J Albrecht
    M Odendahl
    F Schlott
    G Dössinger
    M Schiemann
    S Lakshmipathi
    K Martin
    D Bunjes
    S Harsdorf
    E M Weissinger
    H Menzel
    M Verbeek
    L Uharek
    N Kröger
    E Wagner
    G Kobbe
    T Schroeder
    M Schmitt
    G Held
    W Herr
    L Germeroth
    H Bonig
    T Tonn
    H Einsele
    D H Busch
    G U Grigoleit
    Leukemia, 2017, 31 : 2161 - 2171
  • [7] Kinetics of CMV-specific t-cells from pre-to-posttransplantation predict outcomes in CMV-seronegative kidney transplant recipients
    Schachtner, Thomas
    Stein, Maik
    Reinke, Pera
    TRANSPLANTATION, 2016, 100 (07) : S196 - S196
  • [8] Generation of CMV-Specific Cytotoxic T-Lymphocytes for Adoptive Immunotherapy from Virus-Naive Donors
    Keller, M.
    Hanley, P.
    Bollard, C.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S487 - S488
  • [9] Cytotoxic T Lymphocytes (CTL) Specific for Adenovirus and CMV Can Be Generated from Umbilical Cord Blood for Adoptive Immunotherapy
    Bollard, Catherine M.
    Hanley, Patrick
    Cruz, Conrad Russell
    Leen, Ann M.
    Molldrem, Jeffrey J.
    Liu, Hao
    Gee, Adrian R.
    Heslop, Helen E.
    Dotti, Gianpietro
    Savoldo, Barbara
    Shpall, Elizabeth J.
    BLOOD, 2008, 112 (11) : 1201 - 1202
  • [10] CYTOTOXIC T LYMPHOCYTES (CTL) SPECIFIC FOR ADENOVIRUS AND CMV CAN BE GENERATED FROM UMBILICAL CORD BLOOD FOR ADOPTIVE IMMUNOTHERAPY
    Hanley, P.
    Savoldo, B.
    Cruz, C. R.
    Leen, A. M.
    Molldrem, J. J.
    Liu, H.
    Gee, A. P.
    Heslop, H. E.
    Dotti, G.
    Shpall, E. J.
    Bollard, C. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 17 - 18
123